Beyond the Ovaries: Neurological and Mental Health Risks
At a Glance
Women with an FMR1 premutation can develop age-related neurological symptoms such as tremor, balance problems, nerve symptoms, or cognitive changes, and may experience anxiety or depression. Routine screening is not established, so new symptoms should prompt medical evaluation.
While much of the focus on the FMR1 premutation relates to ovarian health, this genetic trait can also influence other systems in your body. For some women, the premutation carries risks for neurological and mental health concerns that are independent of whether or not they develop FXPOI [1][2].
Understanding these risks is not meant to cause alarm, but to empower you to build a comprehensive care team that looks at your health holistically.
Understanding FXTAS
Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) is an age-related neurological condition that can develop in some carriers as they age. It is much less common in women than in men: while estimates vary by age and criteria, some reviews report approximately 40% of older male carriers develop it, while it occurs in approximately 8% to 16% of female carriers in older cohorts [3][4]. The risk increases with age, and routine neurologic testing in asymptomatic young carriers is not established.
Symptoms of FXTAS typically begin in a person’s 60s and may include:
- Intention Tremor: A shakiness in the hands that occurs when you are performing a specific action, like reaching for a glass or writing [5].
- Ataxia: Difficulty with balance or coordination, which may make your walking seem unsteady [3].
- Neuropathy: Numbness, tingling, or weakness, often starting in the feet or hands [6].
- Cognitive Changes: This might involve “executive function” challenges, such as trouble with planning, organizing, or short-term memory [7].
In women, FXTAS often presents more mildly than in men and may have atypical symptoms, such as prominent psychiatric concerns or subtle balance issues [8][9]. If you notice new or worsening tremors, balance problems, or cognitive changes, seeking an evaluation from a neurologist—ideally one familiar with Fragile X-associated disorders—is recommended rather than scheduling routine surveillance [7].
Mental Health and the Premutation
Many women who carry the FMR1 premutation find that anxiety and depression are part of their experience. Research into how common these are shows a wide range: some clinical studies find high rates of anxiety (up to 37%) and depression (up to 18%), while large population-based studies suggest the risk may be lower [10][11].
These challenges can be influenced by several factors:
- Biology: Some researchers hypothesize the same “mRNA toxicity” that affects the ovaries may also influence brain chemistry, though the size of this independent effect remains uncertain [12].
- Life Stressors: Many carriers are managing the grief associated with POI and are “sandwich generation” caregivers, managing their own health while caring for children with Fragile X Syndrome or aging parents with FXTAS [13].
Anxiety and depression are common, treatable concerns. Seeking support from a mental health professional is a proactive step in managing your overall well-being [10]. If you are experiencing suicidal thoughts or feel unable to keep yourself safe, seek immediate crisis help.
Other Potential Associations
Research has identified a few other conditions that may be seen more frequently in women with the FMR1 premutation, though these are often based on limited or mixed research findings, and routine screening solely because of an FMR1 premutation is not established.
- Thyroid Issues: Some studies suggest that autoimmune thyroid conditions (like hypothyroidism) may be more common in carriers [14][2].
- Sleep Disturbances: Issues like sleep apnea or restless legs syndrome have been reported more frequently by some carriers [15][2].
- Chronic Pain: Some research suggests a possible link to conditions like fibromyalgia or chronic migraines, though results are currently inconsistent [16][15].
Direct your care team to evaluate you if you develop symptoms, rather than assuming they require a broad surveillance program.
Building a Multidisciplinary Team
Because the FMR1 premutation can touch so many parts of your health, primary care can coordinate referrals when symptoms or risks warrant them.
A multidisciplinary team might include:
- A Primary Care Physician to coordinate your overall health and screenings.
- A Genetic Counselor to help you understand the implications for your family [17].
- A Reproductive Endocrinologist to manage FXPOI and fertility.
- A Neurologist and Mental Health Professional to monitor and support your neurological and emotional health [7].
By staying informed and vocal about your symptoms, you can ensure that every part of your health is being supported as you navigate life with the premutation.
Common questions in this guide
What is FXTAS, and when can it appear in FMR1 premutation carriers?
Which neurological changes should women with an FMR1 premutation report?
Do people with an FMR1 premutation need routine testing for FXTAS?
Are anxiety and depression linked to the FMR1 premutation?
Should FMR1 premutation carriers have routine thyroid, sleep, or pain screening?
Who should be part of care for a woman with an FMR1 premutation?
What should I do if I have suicidal thoughts or cannot stay safe?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Neurological checks
Should I have a neurology check if I notice new tremors or balance problems?
Mental health support
Could a mental health professional help with anxiety or low mood as part of my care?
Other health concerns
Should I ask my team to evaluate thyroid problems or sleep disturbances if I develop symptoms?
Get notified when new evidence is published on Fragile X-associated primary ovarian insufficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (17)
- 1
Trajectory and Predictors of Depression and Anxiety Disorders in Mothers With the FMR1 Premutation.
Roberts JE, Tonnsen BL, McCary LM, et al.
Biological psychiatry 2016; (79(10)):850-857 doi:10.1016/j.biopsych.2015.07.015.
PMID: 26300270 - 2
Fragile X premutation in women: recognizing the health challenges beyond primary ovarian insufficiency.
Hoyos LR, Thakur M
Journal of assisted reproduction and genetics 2017; (34(3)):315-323 doi:10.1007/s10815-016-0854-6.
PMID: 27995424 - 3
Differential Progression of Motor Dysfunction Between Male and Female Fragile X Premutation Carriers Reveals Novel Aspects of Sex-Specific Neural Involvement.
Loesch DZ, Tassone F, Atkinson A, et al.
Frontiers in molecular biosciences 2020; (7()):577246 doi:10.3389/fmolb.2020.577246.
PMID: 33511153 - 4
Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications.
Cabal-Herrera AM, Tassanakijpanich N, Salcedo-Arellano MJ, Hagerman RJ
International journal of molecular sciences 2020; (21(12)) doi:10.3390/ijms21124391.
PMID: 32575683 - 5
Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management.
Hagerman RJ, Hagerman P
Nature reviews. Neurology 2016; (12(7)):403-12 doi:10.1038/nrneurol.2016.82.
PMID: 27340021 - 6
Neurological and endocrine phenotypes of fragile X carrier women.
Hall D, Todorova-Koteva K, Pandya S, et al.
Clinical genetics 2016; (89(1)):60-7 doi:10.1111/cge.12646.
PMID: 26212380 - 7
Comprehensive, multidisciplinary care for fragile X-associated tremor/ataxia syndrome.
Bourgeois JA, Schneider A, Klusek J, et al.
Frontiers in neurology 2026; (17()):1746002 doi:10.3389/fneur.2026.1746002.
PMID: 41940304 - 8
Premutation Females with preFXTAS.
Liani V, Torrents C, Rolleri E, et al.
International journal of molecular sciences 2025; (26(6)) doi:10.3390/ijms26062825.
PMID: 40141467 - 9
Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): A Gender Perspective.
Orsucci D, Lorenzetti L, Baldinotti F, et al.
Journal of clinical medicine 2022; (11(4)) doi:10.3390/jcm11041002.
PMID: 35207276 - 10
Psychiatric and Cognitive Features in Italian Women With the FMR1 Premutation: A Comprehensive Assessment Using SCID-5 and Standardized Cognitive Measures.
Montanaro FAM, Hagerman RJ, Spano G, et al.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2026; (201(6)):406-419 doi:10.1002/ajmg.b.70014.
PMID: 41845545 - 11
No association between FMR1 premutation and either ADHD or anxiety in 53,707 women undergoing genetic testing for family planning purposes.
Klausner L, Carmi S, Ben-Shachar S, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2025; (27(7)):101428 doi:10.1016/j.gim.2025.101428.
PMID: 40196935 - 12
Clinical implications of somatic allele expansion in female FMR1 premutation carriers.
Aishworiya R, Hwang YH, Santos E, et al.
Scientific reports 2023; (13(1)):7050 doi:10.1038/s41598-023-33528-x.
PMID: 37120588 - 13
Both cis and trans-acting genetic factors drive somatic instability in female carriers of the FMR1 premutation.
Hwang YH, Hayward BE, Zafarullah M, et al.
Scientific reports 2022; (12(1)):10419 doi:10.1038/s41598-022-14183-0.
PMID: 35729184 - 14
Endocrine Dysfunction in Female FMR1 Premutation Carriers: Characteristics and Association with Ill Health.
Campbell S, Eley SE, McKechanie AG, Stanfield AC
Genes 2016; (7(11)).
PMID: 27869718 - 15
Fragile X syndrome: An overview and update of the FMR1 gene.
Mila M, Alvarez-Mora MI, Madrigal I, Rodriguez-Revenga L
Clinical genetics 2018; (93(2)):197-205 doi:10.1111/cge.13075.
PMID: 28617938 - 16
Advances in exploring the association between FMR1 premutation and fibromyalgia: a pilot study with a more effective sample definition.
Pinheiro MMLS, Antunes MD, Carvalho LML, et al.
Clinics (Sao Paulo, Brazil) 2025; (80()):100758 doi:10.1016/j.clinsp.2025.100758.
PMID: 40916316 - 17
Detecting AGG Interruptions in Females With a FMR1 Premutation by Long-Read Single-Molecule Sequencing: A 1 Year Clinical Experience.
Ardui S, Race V, de Ravel T, et al.
Frontiers in genetics 2018; (9()):150 doi:10.3389/fgene.2018.00150.
PMID: 29868108
This page explains neurological and mental health concerns associated with the FMR1 premutation for informational purposes only; it does not diagnose FXTAS or replace medical advice. Discuss new symptoms or emotional distress with a healthcare professional, and seek immediate crisis help if you cannot stay safe.